Exact Mass: 604.2897
Exact Mass Matches: 604.2897
Found 115 metabolites which its exact mass value is equals to given mass value 604.2897
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Dilazep
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist C - Cardiovascular system > C01 - Cardiac therapy > C01D - Vasodilators used in cardiac diseases D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
4-[4-((R)-alpha-amino-beta-hydroxy-isobutyrylamino)-benzoylamino]-1-[O4-(4-methylamino-4,6-dideoxy-alpha-D-glucopyranosyl)-beta-D-erythro-2,3,6-trideoxy-hexopyranosyl]-1H-pyrimidin-2-one|4-[4-((R)-alpha-Amino-beta-hydroxy-isobutyrylamino)-benzoylamino]-1-[O4-(4-methylamino-4,6-didesoxy-alpha-D-glucopyranosyl)-beta-D-erythro-2,3,6-tridesoxy-hexopyranosyl]-1H-pyrimidin-2-on|bamicetin
(1S,2S,3S,4S,4aR,4bR,5aS,6R,6aR,9aR,9bR)-1,2,3,4,4a,4b,5a,6,6a,7,9a,9b-dodecahydro-3,6,6a,9b-tetrahydroxy-5a-(hydroxymethyl)-1,8-dimethyl-3-(1-methylethenyl)-7-oxo-2-(1-oxopropoxy)benz[7,8]azuleno[5,6-b]oxiren-4-yl (2E,4E)-deca-2,4-dienoate|yuanhuaoate C
(1aS,1bR,2aS,3aS,4R,4aS,6S,6aS,7R,8R,11R,12S,13cS)-4,6-bis(acetyloxy)icosahydro-1b,11-dihydroxy-7-(hydroxymethyl)-4a,6a,11,12-tetramethyl-8,12-methanobisoxireno[3,4:6,7]naphtho[2,1:4,5]indeno[1,2-d]oxocin-10(2H)-one|taccalonolide Y
16beta-acetoxystrophanthidin-4,6-dideoxy-2,3-methylenedioxy-beta-D-allopyranoside|reevesioside B
16beta-O-acetyl-scillarenin-3-O-beta-D-glucoside|3-O-beta-Glucopyranoside,16-Ac-3,14,16-Trohydroxybufa-4,20,22-trienolide
cinobufagin 3-O-beta-D-glucopyranoside|cinobufagin 3-O-beta-D-glucoside
Phe Ile Tyr Tyr
Phe Leu Tyr Tyr
Phe Tyr Ile Tyr
Phe Tyr Leu Tyr
Phe Tyr Tyr Ile
Phe Tyr Tyr Leu
Ile Phe Tyr Tyr
Ile Tyr Phe Tyr
Ile Tyr Tyr Phe
Leu Phe Tyr Tyr
Leu Tyr Phe Tyr
Leu Tyr Tyr Phe
Tyr Phe Ile Tyr
Tyr Phe Leu Tyr
Tyr Phe Tyr Ile
Tyr Phe Tyr Leu
Tyr Ile Phe Tyr
Tyr Ile Tyr Phe
Tyr Leu Phe Tyr
Tyr Leu Tyr Phe
Tyr Tyr Phe Ile
Tyr Tyr Phe Leu
Tyr Tyr Ile Phe
Tyr Tyr Leu Phe
ST 26:6;O6;Hex
N,N-Di(4-biphenylyl)-N-(9,9-dimethyl-9H-fluoren-2-yl)-1,4-benzen ediamine
butane-1,4-diol,hexanedioic acid,hexane-1,6-diol,1-isocyanato-4-[(4-isocyanatophenyl)methyl]benzene
(2S)-2-[12-ethyl-8-(hydroxymethyl)-9-oxo-2-(4-piperidin-1-ylpiperidine-1-carbonyl)oxy-11H-indolizino[1,2-b]quinolin-7-yl]-2-hydroxybutanoic acid
Dilazep
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist C - Cardiovascular system > C01 - Cardiac therapy > C01D - Vasodilators used in cardiac diseases D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
(2S,3S,4S,5Z)-4-(2-carboxyethyl)-5-[2-[[5-[(3-ethenyl-4-methyl-5-oxo-1,2-dihydropyrrol-2-yl)methyl]-3-ethyl-4-methyl-1H-pyrrol-2-yl]methyl]-3-methyl-4,5-dioxo-3a,6a-dihydro-1H-cyclopenta[b]pyrrol-6-ylidene]-3-methylpyrrolidine-2-carboxylic acid
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclohexanecarboxamide
1-(1,3-benzodioxol-5-yl)-3-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea
2-[[(5S,6R,9R)-5-methoxy-14-[[(2-methoxyanilino)-oxomethyl]amino]-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-8-yl]methyl]benzoic acid
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclohexanecarboxamide
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclohexanecarboxamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclohexanecarboxamide
1-(1,3-benzodioxol-5-yl)-3-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclohexanecarboxamide
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclohexanecarboxamide
1-(1,3-benzodioxol-5-yl)-3-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea
N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclohexanecarboxamide
1-(1,3-benzodioxol-5-yl)-3-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea
1-(1,3-benzodioxol-5-yl)-3-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclohexanecarboxamide
[(1R,2R,3R,4S,5R,6S,7S,9R,10R,11S,14R,15R,16S,24S,26S)-10-hydroxy-9-(hydroxymethyl)-2,14,16-trimethyl-12-oxo-4-prop-1-en-2-yl-8,13,25,27,28,29-hexaoxaoctacyclo[13.10.1.14,24.15,24.111,14.01,6.07,9.011,26]nonacosan-3-yl] acetate
[(1R,2R,3R,4S,5R,6S,7S,9R,10R,11S,14R,15R,16R,24S,26S)-10-hydroxy-9-(hydroxymethyl)-2,14,16-trimethyl-12-oxo-4-prop-1-en-2-yl-8,13,25,27,28,29-hexaoxaoctacyclo[13.10.1.14,24.15,24.111,14.01,6.07,9.011,26]nonacosan-3-yl] acetate
(1r,2r,4s,5r,6r,10r,11r,12s,13s,14s,15s)-13-(acetyloxy)-5,6,11,14-tetrahydroxy-4-(hydroxymethyl)-8,12-dimethyl-7-oxo-14-(prop-1-en-2-yl)-3-oxatetracyclo[9.4.0.0²,⁴.0⁶,¹⁰]pentadec-8-en-15-yl (2e,4e)-deca-2,4-dienoate
(1s,2s,4s,5r,7s,9s,10r,11s,12s,14s,16r,17s,19s)-10-(acetyloxy)-5,17-dihydroxy-16-[(1s)-1-[(2r)-5-(hydroxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-11,15-dimethyl-3,8-dioxahexacyclo[10.7.0.0²,⁴.0⁵,¹¹.0⁷,⁹.0¹⁵,¹⁹]nonadecan-14-yl acetate
9-(acetyloxy)-10,22-dihydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosan-20-yl acetate
(1r,4s)-4-[(2r,4ar,6r,8as)-6-[(2s,5r)-5-bromo-2,6,6-trimethyloxan-2-yl]-8a-methyl-hexahydro-2h-pyrano[3,2-b]pyran-2-yl]-1-[(2s,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]pentane-1,4-diol
6β-acetoxy scillarenin 3-o-β-d-glucopyranoside
{"Ingredient_id": "HBIN012253","Ingredient_name": "6\u03b2-acetoxy scillarenin 3-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C32H44O11","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "278","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}